Timing of drotrecogin alfa (activated) treatment in severe sepsis
- PMID: 16934134
- PMCID: PMC1750968
- DOI: 10.1186/cc5010
Timing of drotrecogin alfa (activated) treatment in severe sepsis
Comment on
-
Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis.Crit Care. 2006;10(3):R74. doi: 10.1186/cc4909. Epub 2006 May 9. Crit Care. 2006. PMID: 16684364 Free PMC article.
References
-
- Girbes ARJ, Bakker J, van Deuren M, van Hout BA, van Leeuwen SJ, Levi M, Schultz MJ, van Zanten ARH. Toepassing drotrecogin alpha, geactiveerd proteine C (aPC) bij de behandeling van ernstige sepsis. Neth J Crit Care. 2005;9:165–166.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
